<!DOCTYPE html>
<!-- Generated by PHPWord -->
<html>
<head>
<meta charset="UTF-8" />
<title>PHPWord</title>
<meta name="author" content="Ronan Whelan" />
<style>
* {font-family: Arial; font-size: 10pt;}
a.NoteRef {text-decoration: none;}
hr {height: 1px; padding: 0; margin: 1em 0; border: 0; border-top: 1px solid #CCC;}
table {border: 1px solid black; border-spacing: 0px; width: 100%;}
td {border: 1px solid black;}
.NormalWeb {font-family: 'Times New Roman';}
</style>
</head>
<body>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p style="margin-top: 0pt;"><span style="font-family: 'Arial'; font-size: 9pt; color: #172A3A; font-weight: bold;">﻿﻿INTRODUCTION</span></p>
<p style="margin-top: 0pt;"></p>
<p style="margin-top: 0pt;"><span style="font-family: 'Calibri'; font-size: 9pt; color: #172A3A;">This report is to summarize the results and outcome of the Risk Assessment for the new </span></p>
<p style="margin-top: 0pt;"></p>
<p style="margin-top: 0pt;"><span style="font-family: 'Calibri'; font-size: 9pt; color: #172A3A;">Mundipharma</span></p>
<p style="margin-top: 0pt;"></p>
<p style="margin-top: 0pt;"><span style="font-family: 'Calibri'; font-size: 9pt; color: #172A3A;"> Plant, a Greenfield site at Plot 4, 10 </span></p>
<p style="margin-top: 0pt;"></p>
<p style="margin-top: 0pt;"><span style="font-family: 'Calibri'; font-size: 9pt; color: #172A3A;">Tuas</span></p>
<p style="margin-top: 0pt;"></p>
<p style="margin-top: 0pt;"><span style="font-family: 'Calibri'; font-size: 9pt; color: #172A3A;"> South Avenue 14, </span></p>
<p style="margin-top: 0pt;"></p>
<p style="margin-top: 0pt;"><span style="font-family: 'Calibri'; font-size: 9pt; color: #172A3A;">Tuas</span></p>
<p style="margin-top: 0pt;"></p>
<p style="margin-top: 0pt;"><span style="font-family: 'Calibri'; font-size: 9pt; color: #172A3A;"> Industrial Estate, Singapore.  The new production facility shall be used for the manufacturing and filling of Betadine® antiseptic liquid products.</span></p>
<p style="margin-top: 0pt;"></p>
<p style="margin-top: 0pt;"><span style="font-family: 'Arial'; font-size: 10pt; color: #172A3A; font-weight: bold;">﻿﻿</span></p>
<p style="margin-top: 0pt;"><span style="font-family: 'Arial'; font-size: 9pt; color: #172A3A; font-weight: bold;">PURPOSE</span></p>
<p style="margin-top: 0pt;"></p>
<p style="margin-top: 0pt;"><span style="font-family: 'Calibri'; font-size: 9pt; color: #172A3A;">The purpose of the Risk Assessment is to identify potential failures and causes of the failures, associated with the facility and process design </span></p>
<p style="margin-top: 0pt;"></p>
<p style="margin-top: 0pt;"><span style="font-family: 'Calibri'; font-size: 9pt; color: #172A3A;">in order to</span></p>
<p style="margin-top: 0pt;"></p>
<p style="margin-top: 0pt;"><span style="font-family: 'Calibri'; font-size: 9pt; color: #172A3A;"> prevent or reduce the occurrence of these causes thereby mitigating the risk to the patient.  The outcome of the assessment shall summarize the risks that require design action or further </span></p>
<p style="margin-top: 0pt;"></p>
<p style="margin-top: 0pt;"><span style="font-family: 'Calibri'; font-size: 9pt; color: #172A3A;">analysis ,</span></p>
<p style="margin-top: 0pt;"></p>
<p style="margin-top: 0pt;"><span style="font-family: 'Calibri'; font-size: 9pt; color: #172A3A;"> if any and also determine the appropriate level of </span></p>
<p style="margin-top: 0pt;"></p>
<p style="margin-top: 0pt;"><span style="font-family: 'Calibri'; font-size: 9pt; color: #172A3A;">qualitication</span></p>
<p style="margin-top: 0pt;"></p>
<p style="margin-top: 0pt;"><span style="font-family: 'Calibri'; font-size: 9pt; color: #172A3A;"> and testing (Test Matrix) required for the system, in order to remediate the risks identified.</span></p>
<p style="margin-top: 0pt;"><span style="font-family: 'Arial'; font-size: 9pt; color: #172A3A; font-weight: bold;">SCOPE</span></p>
<p style="margin-top: 0pt;"><span style="font-family: 'Calibri'; font-size: 9pt; color: #172A3A;">The scope of the assessment is confined to Direct Impact Systems which has been identified through the System Level Impact Assessment per PES-SOP-002.</span></p>
<p>&nbsp;</p>
<table>
<tr>
<td>
<p>Instruction</p>
</td>
<td>
<p>Data In</p>
</td>
<td>
<p>Data Out</p>
</td>
<td>
<p>Result</p>
</td>
<td>
<p>Sign / Date</p>
</td>
</tr>
<tr>
<td>
<p><span style="font-family: 'Helvetica Neue'; font-size: 10pt; color: #172A3A;">Add the instruction of the text here</span></p>
<p>&nbsp;</p>
</td>
<td>
<p><span style="font-family: 'Helvetica Neue'; font-size: 10pt; color: #172A3A;">[model-number]</span></p>
<p>&nbsp;</p>
</td>
<td>
<p>[ attribute = serial-number]</p>
</td>
<td>
<p>&nbsp;</p>
</td>
<td>
<p>&nbsp;</p>
</td>
</tr>
<tr>
<td>
<p><span style="font-family: 'Helvetica Neue'; font-size: 10pt; color: #172A3A;">Add the instruction of the text here</span></p>
<p>&nbsp;</p>
</td>
<td>
<p><span style="font-family: 'Helvetica Neue'; font-size: 10pt; color: #172A3A;">[model-number]</span></p>
<p>&nbsp;</p>
</td>
<td>
<p>[ attribute = serial-number]</p>
</td>
<td>
<p>&nbsp;</p>
</td>
<td>
<p>&nbsp;</p>
</td>
</tr>
<tr>
<td>
<p><span style="font-family: 'Helvetica Neue'; font-size: 10pt; color: #172A3A;">Add the instruction of the text here</span></p>
<p>&nbsp;</p>
</td>
<td>
<p><span style="font-family: 'Helvetica Neue'; font-size: 10pt; color: #172A3A;">[model-number]</span></p>
<p>&nbsp;</p>
</td>
<td>
<p>[ attribute = serial-number]</p>
</td>
<td>
<p>&nbsp;</p>
</td>
<td>
<p>&nbsp;</p>
</td>
</tr>
<tr>
<td>
<p><span style="font-family: 'Helvetica Neue'; font-size: 10pt; color: #172A3A;">Add the instruction of the text here</span></p>
<p>&nbsp;</p>
</td>
<td>
<p><span style="font-family: 'Helvetica Neue'; font-size: 10pt; color: #172A3A;">[model-number]</span></p>
<p>&nbsp;</p>
</td>
<td>
<p>[ attribute = serial-number]</p>
</td>
<td>
<p>&nbsp;</p>
</td>
<td>
<p>&nbsp;</p>
</td>
</tr>
</table>
<p>&nbsp;</p>
<p style="margin-top: 0pt;"><span style="font-family: 'Calibri'; font-size: 9pt; color: #172A3A; font-weight: bold;">METHOD</span></p>
<p style="margin-top: 0pt;"></p>
<p style="margin-top: 0pt;"><span style="font-family: 'Calibri'; font-size: 9pt; color: #172A3A;">The Risk Assessment was performed using Figaro per PES-SOP-003, which utilize the process Failure Modes Effects and Criticality Analysis (PFMECA) methodology to identify the possible failure modes and ranks their overall impact based on their individual</span></p>
<p style="margin-top: 0pt;"><span style="font-family: 'Calibri'; font-size: 9pt; color: #172A3A;"> </span></p>
<p style="margin-top: 0pt;"><span style="font-family: 'Calibri'; font-size: 9pt; color: #172A3A; font-style: italic;">Severity (1-10),</span></p>
<p style="margin-top: 0pt;"><span style="font-family: 'Calibri'; font-size: 9pt; color: #172A3A;"> </span></p>
<p style="margin-top: 0pt;"><span style="font-family: 'Calibri'; font-size: 9pt; color: #172A3A; font-style: italic;">Probability (1-10)</span></p>
<p style="margin-top: 0pt;"><span style="font-family: 'Calibri'; font-size: 9pt; color: #172A3A;"> </span></p>
<p style="margin-top: 0pt;"><span style="font-family: 'Calibri'; font-size: 9pt; color: #172A3A;">and</span></p>
<p style="margin-top: 0pt;"><span style="font-family: 'Calibri'; font-size: 9pt; color: #172A3A;"> </span></p>
<p style="margin-top: 0pt;"></p>
<p style="margin-top: 0pt;"><span style="font-family: 'Calibri'; font-size: 9pt; color: #172A3A; font-style: italic;">Detectibility</span></p>
<p style="margin-top: 0pt;"></p>
<p style="margin-top: 0pt;"><span style="font-family: 'Calibri'; font-size: 9pt; color: #172A3A; font-style: italic;"> (1-10</span></p>
<p style="margin-top: 0pt;"></p>
<p style="margin-top: 0pt;"><span style="font-family: 'Calibri'; font-size: 9pt; color: #172A3A; font-style: italic;">)</span></p>
<p style="margin-top: 0pt;"><span style="font-family: 'Calibri'; font-size: 9pt; color: #172A3A;"> </span></p>
<p style="margin-top: 0pt;"><span style="font-family: 'Calibri'; font-size: 9pt; color: #172A3A;">.</span></p>
<p style="margin-top: 0pt;"></p>
<p style="margin-top: 0pt;"><span style="font-family: 'Calibri'; font-size: 9pt; color: #172A3A; font-weight: bold;">DEFINITION</span></p>
<p style="margin-top: 0pt;"><span style="font-family: 'Calibri'; font-size: 9pt; color: #172A3A;">Refer to the Standard Operating Procedure (SOP) for Risk Assessment and Test Matrix, PES-SOP-003 for the definition of acronyms e.g. CPP, RPN and risk score or rating.</span></p>
<p style="margin-top: 0pt;"><span style="font-family: 'Calibri'; font-size: 9pt; color: #172A3A; font-weight: bold;">CONCLUSION</span></p>
<p style="margin-top: 0pt;"></p>
<p style="margin-top: 0pt;"><span style="font-family: 'Calibri'; font-size: 9pt; color: #172A3A;">A Risk Assessment for the new </span></p>
<p style="margin-top: 0pt;"></p>
<p style="margin-top: 0pt;"><span style="font-family: 'Calibri'; font-size: 9pt; color: #172A3A;">Mundipharma</span></p>
<p style="margin-top: 0pt;"></p>
<p style="margin-top: 0pt;"><span style="font-family: 'Calibri'; font-size: 9pt; color: #172A3A;"> Plant – Greenfield Project have been performed and the results are documented in Appendix 1 to this document.  Furthermore, the generated Test Matrix documented in Appendix 2 have been identified for testing and qualification to mitigate the risks identified in the assessment. </span></p>
<p>&nbsp;</p>
</body>
</html>
